In a year that has seen an approval and a raft of readouts for metabolic dysfunction-associated steatohepatitis (MASH), ...

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To ...

Gilead will pay a fee of $315 million if it takes the option, and up to $1.15 billion in future milestone payments. It will also provide Pionyr with additional funding to develop PY314 and PY159 ...

How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...

Vaccine biotech Gritstone bio is filing for bankruptcy while securing a stalking horse bid from an unnamed party, which the ...

Discover the top biotech companies pioneering the next healthcare breakthroughs. Learn how innovative firms are ...

Nurix Therapeutics offers promising targeted protein degradation treatments for cancer and autoimmune diseases. Find out what ...

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in September 2024.

An LLC model in biotech brings specific advantages, such as streamlined deal-making, IP ownership, and capital reinvestment ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news delivered straight to your inbox. Hello, hello. Today we talk ...

Despite a 7% YTD gain, IBB ETF has underperformed the S&P 500, which is up 21%, and shows negative alpha. Read more on IBB ...

The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst ...